Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

BACKGROUND: Improved knowledge of the molecular pathophysiology and immunopathogenesis of cholestatic liver diseases in recent years has led to an increased interest in developing novel therapies. Patients with cholestatic liver disease often require different approaches to assessment and management...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Melissa, Regev, Arie, Lindor, Keith, Avigan, Mark I., Dimick‐Santos, Lara, Treem, William, Marcinak, John F., Lewis, James H., Anania, Frank A., Seekins, Daniel, Shneider, Benjamin L., Chalasani, Naga, Dash, Ajit, Krishna, Gopal, Lonjon‐Domanec, Isabelle, Maller, Eric, Patel, Niti, Patwardhan, Meenal, Raheja, Ritu, Lilly, Eli, Treem, William R., Wuchter‐Czerwony, Christian, Zhang, Hui‐Talia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Consensus Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972572/
https://www.ncbi.nlm.nih.gov/pubmed/31762074
http://dx.doi.org/10.1111/apt.15579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972572/
https://www.ncbi.nlm.nih.gov/pubmed/31762074
http://dx.doi.org/10.1111/apt.15579

Ejemplares similares